Decreased endogenous secretory RAGE and increased hsCRP levels in serum are associated with atrial fibrillation in patients undergoing coronary angiography

International Journal of Cardiology

Volumn 166, Issue 1, 2013, Pages 242-245

  Yan, Xiaoxiang ^a,b   Shen, Ying ^a   Lu, Lin ^a   Sano, Motoaki ^b   Fukuda, Keiichi ^b   Shen, Weifeng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced glycation end products; Atrial fibrillation; Coronary artery disease; Glycated albumin; Inflammatory cytokine; Type 2 diabetes mellitus

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; C REACTIVE PROTEIN; GLYCOSYLATED ALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 84877747837     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.08.055     Document Type: Article

References (21)

1. D.E. Singer, G.W. Albers, J.E. Dalen, A.S. Go, J.L. Halperin, and W.J. Manning Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 2004 429S 456S
2. F.W. Asselbergs, M.P. van den Berg, G.F. Diercks, W.H. van Gilst, and D.J. van Veldhuisen C-reactive protein and microalbuminuria are associated with atrial fibrillation Int J Cardiol 98 2005 73 77
3. S. Nattel, B. Burstein, and D. Dobrev Atrial remodeling and atrial fibrillation: mechanisms and implications Circ Arrhythm Electrophysiol 1 2008 62 73
4. T. Kato, T. Yamashita, and A. Sekiguchi AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat J Cardiovasc Electrophysiol 19 2008 415 420
5. L. van Heerebeek, N. Hamdani, and M.L. Handoko Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension Circulation 117 2008 43 51
6. S. Raposeiras-Roubin, B.K. Rodino-Janeiro, and L. Grigorian-Shamagian Evidence for a role of advanced glycation end products in atrial fibrillation Int J Cardiol 157 2012 397 402
7. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation) Eur Heart J 27 2006 1979 2030
8. A.J. Coats, and L.G. Shewan Statement on authorship and publishing ethics in the international journal of cardiology Int J Cardiol 153 2011 239 240
9. L. Lu, L.J. Pu, and Q. Zhang Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes Atherosclerosis 206 2009 540 545
10. X.X. Yan, L. Lu, and W.H. Peng Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients Atherosclerosis 205 2009 544 548
11. T. Nishikawa, D. Edelstein, and X.L. Du Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage Nature 404 2000 787 790
12. A. Goldin, J.A. Beckman, A.M. Schmidt, and M.A. Creager Advanced glycation end products: sparking the development of diabetic vascular injury Circulation 114 2006 597 605
13. M.R. Movahed, M. Hashemzadeh, and M.M. Jamal Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease Int J Cardiol 105 2005 315 318
14. M.A. Hofmann, S. Drury, and C. Fu RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 97 1999 889 901
15. H. Koyama, H. Yamamoto, and Y. Nishizawa RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases Mol Med 13 2007 625 635
16. K. Higai, A. Shimamura, and K. Matsumoto Amadori-modified glycated albumin predominantly induces E-selectin expression on human umbilical vein endothelial cells through NADPH oxidase activation Clin Chim Acta 367 2006 137 143
17. M. Zhang, A.L. Kho, and N. Anilkumar Glycated proteins stimulate reactive oxygen species production in cardiac myocytes: involvement of Nox2 (gp91phox)-containing NADPH oxidase Circulation 113 2006 1235 1243
18. H. Yonekura, Y. Yamamoto, S. Sakurai, T. Watanabe, and H. Yamamoto Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury J Pharmacol Sci 97 2005 305 311
19. H. Yonekura, Y. Yamamoto, and S. Sakurai Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury Biochem J 370 2003 1097 1109
20. L.J. Wang, L. Lu, F.R. Zhang, Q.J. Chen, R. De Caterina, and W.F. Shen Increased serum high-mobility group box-1 and cleaved receptor for advanced glycation endproducts levels and decreased endogenous secretory receptor for advanced glycation endproducts levels in diabetic and non-diabetic patients with heart failure Eur J Heart Fail 13 2011 440 449
21. N. Hagiwara Inflammation and atrial fibrillation Circ J 74 2010 246 247